Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers
<b>Background/Objectives</b>: Cancer is caused by disruptions in the homeostatic state of normal cells, which results in dysregulation of the cell cycle, and uncontrolled growth and proliferation in affected cells to form tumors. Successful development of tumorous cells proceeds through...
Saved in:
Main Authors: | Gautam Kundu, Selvakumar Elangovan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/173 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of intensity normalization methods in prostate, brain, and breast cancer multi-parametric magnetic resonance imaging
by: Savannah R. Duenweg, et al.
Published: (2025-02-01) -
A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01) -
Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
by: Francesco Bertoldo, et al.
Published: (2025-02-01) -
Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
by: Shengkai Jin, et al.
Published: (2025-01-01) -
Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer
by: I. S. Ignatov, et al.
Published: (2025-02-01)